Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (20)

2024

  1. Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

    Clinical and Translational Oncology, Vol. 26, Núm. 8, pp. 1896-1907

2020

  1. First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study

    Journal of Geriatric Oncology, Vol. 11, Núm. 8, pp. 1263-1267

2019

  1. In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from trametes versicolor and grifola frondosa in colon cancer cells

    International Journal of Medical Sciences, Vol. 16, Núm. 2, pp. 231-240

2017

  1. Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysis

    Journal of Cancer Research and Therapeutics, Vol. 13, Núm. 2, pp. 240-245

  2. Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System

    Journal of Proteome Research, Vol. 16, Núm. 8, pp. 2773-2788

2015

  1. Colorectal cancer classification and cell heterogeneity: A systems oncology approach

    International Journal of Molecular Sciences, Vol. 16, Núm. 6, pp. 13610-13632

2013

  1. Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: A retrospective study

    Anticancer Research, Vol. 33, Núm. 9, pp. 4089-4096

  2. ¿bevacizumab hasta la progresión?

    Revisiones en Cancer, Vol. 27, pp. 102-105

2011

  1. Tratamiento adyuvante del cáncer de colon en estadio III

    Revisiones en Cancer, Vol. 25, Núm. 2, pp. 53-61

2009

  1. MicroRNAs as circulating tumor cells biomarkers in gastrointestinal cancer

    EJC SUPPLEMENTS

  2. Transcribed ultraconserved elements expression in tumour cell lines

    EJC SUPPLEMENTS

2008

  1. Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

  2. Effectiveness of COX2 inhibitor treatment in patients with dysplastic oral leukoplakia

    EJC SUPPLEMENTS

  3. Utility of p53 gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

2007

  1. Prostate cancer and Hedgehog signalling pathway

    Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 420-428

2006

  1. Subacute cerebellar degeneration as paraneoplastic syndrome: Initial symptom of breast cancer with HER2 overexpression

    Clinical Breast Cancer, Vol. 7, Núm. 1, pp. 79-80

2003

  1. Bioquimioterapia ambulatoria con cisplatino, dacarbacina, interleucina-2 e interferón-alfa en pacientes con melanoma avanzado. Estudio multicéntrico en 44 pacientes

    Clinical and Translational Oncology, Vol. 5, Núm. 2, pp. 79-87

2001

  1. Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

    Cancer, Vol. 91, Núm. 4, pp. 704-711

1997

  1. Acute liver failure as presentation form of small cell carcinoma of the lung

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 14, Núm. 3, pp. 128-130

  2. Eritropoyetina recombinante humana en el tratamiento de la anemia de mieloma multiple [1]

    Anales de Medicina Interna